The COMPARE trial is an open-label, randomized, controlled Phase 1/2 study evaluating KYV-101 against the anti-CD20 monoclonal antibody rituximab in patients with anti-citrullinated protein antibody ...
The Neuro Sharp supplement translates this natural wisdom into a practical, easy-to-use daily formula. By combining specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback